Statins use and the risk of all and subtype hematological malignancies: a meta‐analysis of observational studies. (21st March 2015)

• Record Type: Journal Article
• Authors: Pradelli, Danitza; Soranna, Davide; Zambon, Antonella; Catapano, Alberico; Mancia, Giuseppe; La Vecchia, Carlo; Corrao, Giovanni
• Is Part Of: Cancer medicine. Volume 4:Number 5(2015:May)
• Page Start: 770
• Page End: 780
• Publication Date: 2015-03-21
• Subjects: 616.994005
• DOI: 10.1002/cam4.411
• Languages: English
• ISSNs: 2045-7634

Abstract

<abstract abstract-type="graphical" xml:lang="en" id="cam4411-abs-0002"> <title> <x xml:space="preserve">Abstract</x> </title> <p>In order to quantify the association between use of statins and the risk of all hematological malignancies and of subtypes, we performed a meta‐analysis of observational studies. Our study provides evidence that statins seem to reduce the risk of hematological malignancy. We also found that statins users had a significant reduced risk of leukemia and non‐Hodgkin lymphoma than nonusers. <graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgjmx2c3gh" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></p> </abstract>